about
Serologic survey of pandemic (H1N1) 2009 virus, Guangxi Province, ChinaThe Therapeutic Effect of Pamidronate on Lethal Avian Influenza A H7N9 Virus Infected Humanized MiceAvian influenza A H7N9 virus induces severe pneumonia in mice without prior adaptation and responds to a combination of zanamivir and COX-2 inhibitorClinical and virological factors associated with viremia in pandemic influenza A/H1N1/2009 virus infectionHuman infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome.Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic?Avian influenza A H5N1 virus: a continuous threat to humans.Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia.Novel avian-origin human influenza A(H7N9) can be transmitted between ferrets via respiratory droplets.Evolution and adaptation of H5N1 influenza virus in avian and human hosts in Indonesia and Vietnam.Emergence and predominance of an H5N1 influenza variant in China.Evolution and molecular epidemiology of H9N2 influenza A viruses from quail in southern China, 2000 to 2005.The genesis and evolution of H9N2 influenza viruses in poultry from southern China, 2000 to 2005A model to control the epidemic of H5N1 influenza at the source.Identification of the progenitors of Indonesian and Vietnamese avian influenza A (H5N1) viruses from southern ChinaEvolutionary dynamics and emergence of panzootic H5N1 influenza viruses.Dating the emergence of pandemic influenza virusesDifferential susceptibility of different cell lines to swine-origin influenza A H1N1, seasonal human influenza A H1N1, and avian influenza A H5N1 viruses.Oseltamivir-resistant influenza A pandemic (H1N1) 2009 virus, Hong Kong, China.Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection.Human H7N9 virus induces a more pronounced pro-inflammatory cytokine but an attenuated interferon response in human bronchial epithelial cells when compared with an epidemiologically-linked chicken H7N9 virus.Hemagglutinin amino acids related to receptor specificity could affect the protection efficacy of H5N1 and H7N9 avian influenza virus vaccines in mice.Quasispecies of the D225G substitution in the hemagglutinin of pandemic influenza A(H1N1) 2009 virus from patients with severe disease in Hong Kong, China.Mycophenolic acid, an immunomodulator, has potent and broad-spectrum in vitro antiviral activity against pandemic, seasonal and avian influenza viruses affecting humans.Molecular characterization of in vivo adjuvant activity in ferrets vaccinated against influenza virusEffect of clinical and virological parameters on the level of neutralizing antibody against pandemic influenza A virus H1N1 2009.D225G mutation in hemagglutinin of pandemic influenza H1N1 (2009) virus enhances virulence in mice.Wild type and mutant 2009 pandemic influenza A (H1N1) viruses cause more severe disease and higher mortality in pregnant BALB/c miceDifferences in antibody responses of individuals with natural infection and those vaccinated against pandemic H1N1 2009 influenza.Long-term evolution and transmission dynamics of swine influenza A virus.Novel reassortment of Eurasian avian-like and pandemic/2009 influenza viruses in swine: infectious potential for humans.High incidence of severe influenza among individuals over 50 years of age.Transcription of BamHI-A region of the EBV genome in NPC tissues and B cells.Distribution of amantadine-resistant H5N1 avian influenza variants in Asia.Evolutionary insights into the ecology of coronaviruses.Peptide mimics of a conserved H5N1 avian influenza virus neutralization site.Clinical, virological, and histopathological manifestations of fatal human infections by avian influenza A(H7N9) virus.Nuclear factor 90 negatively regulates influenza virus replication by interacting with viral nucleoprotein.Identification of influenza A nucleoprotein as an antiviral target.GC/MS-based metabolomics reveals fatty acid biosynthesis and cholesterol metabolism in cell lines infected with influenza A virus.
P50
Q24633856-3952CB14-D723-45F0-8014-E36E177918CDQ27322928-293685BD-16D5-44A2-9562-9266CE57B326Q28543086-075AB782-A6FE-4414-BBB6-D380CB9DB30BQ28744529-376B5E6A-3220-4B90-AB74-EA65C321D679Q30223081-A38BE0BF-12A7-4E5C-B08C-CCD87EC1D72AQ30223960-79B83D67-838F-492B-B3C2-7D7F96A67647Q30224462-2ADA4A3D-D5C4-4A4C-92E5-FB82CA755B47Q30342179-0E94EFBF-482B-4A1E-87F3-A47BE15A3605Q30353256-58E4564D-6131-4F1C-987F-E9D192A3DC22Q30354492-762D548C-9178-4A11-BE26-357036EFDCEAQ30357743-0EB82EF0-C202-4130-B1E7-63D09F156876Q30358972-6C9C6B57-E89A-46D7-88FE-6D0352FCA595Q30363051-03AC3D05-4400-46A2-A75B-4BD90585B363Q30365792-1796832C-0E12-4D51-8BDA-EC086FF78BBAQ30367318-8FA97FC8-78C0-4348-B8B2-150D0FA8EC97Q30372285-ED5D166B-AF1F-428E-8E85-F53942C3F121Q30378899-8E6714C2-DD6F-4C79-8F45-8C7DBEDD3E55Q30381310-B7DFD812-1464-4B43-917E-BB171A56E792Q30383194-067E86B8-E013-448C-A6E9-BA7D57D517BDQ30385421-622CF9E7-2254-4230-9E03-1AEAEF008A3FQ30385648-66FEBB50-07BE-4DA3-9FFA-36E792CBA0ABQ30386963-E893971B-5D81-4D85-8AD0-469A703754F5Q30387660-60B0017F-642B-450D-8397-83A08BB8C7CBQ30388904-6F222560-823F-4860-8DB2-D60C26CB0B6CQ30390170-9E5301D0-83FC-4D66-AEA0-863E59FE17CEQ30390693-EDF5716A-144D-4AEE-84E3-7D3709DA070FQ30391849-184B03EC-0DCC-42C5-9E7F-0C0F90B16FF4Q30396013-6B867378-AEB6-4713-8BDD-EC4964319897Q30400817-B04DD24E-A6DB-40E5-80F9-DDD60B830C7EQ30403142-F9C3D7AD-235D-4D99-82AD-013E531F4955Q30406092-05CACAA1-0DAA-495A-888F-78F0EA60FDB9Q30406838-036003B3-9375-4B00-A798-94D4D3E81CC2Q33189141-8241EF63-3D5E-4A8A-B0CC-EA25D51E6F29Q33243576-7496AF29-6A08-402B-B0A3-2B8EBFC75C1FQ33271263-CD0F9B64-ABD7-4AA5-8A06-A5DF5B593366Q33381357-A68B0E55-44A8-4C5A-9458-0C9139E51DE9Q33409780-4747187B-FD4A-4188-B0C9-561267D290A0Q33459671-6CFC701F-D86D-41C3-809B-CE1A060CC8FBQ33590644-784A65D0-E1C2-4F94-A4CF-DA883B23B769Q33733982-5DF79B50-A954-4746-BBC1-E5FEC13F44EE
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Honglin Chen
@ast
Honglin Chen
@en
Honglin Chen
@es
Honglin Chen
@sl
type
label
Honglin Chen
@ast
Honglin Chen
@en
Honglin Chen
@es
Honglin Chen
@sl
prefLabel
Honglin Chen
@ast
Honglin Chen
@en
Honglin Chen
@es
Honglin Chen
@sl
P1053
C-4224-2009
P106
P1153
26643315400
57190856052
P31
P3829
P496
0000-0001-5108-8338